Ishibashi, Japan

Noboru Kawaguchi


Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Ishibashi, JP (1990)
  • Tochigi-ken, JP (1996)

Company Filing History:


Years Active: 1990-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Noboru Kawaguchi: Innovator in Pharmaceutical Chemistry

Introduction

Noboru Kawaguchi is a distinguished inventor based in Ishibashi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that enhance brain function and memory.

Latest Patents

Kawaguchi holds 2 patents, with his latest innovations focusing on two key areas. The first patent involves hexahydropyrano [3,2-B] [1,4] benzothiazine derivatives. These compounds are designed to facilitate the metabolic turnover of inositol phospholipids in the hippocampus, which plays a crucial role in memory. They are intended to improve cerebral function and can be utilized as agents for activating brain metabolism. The second patent pertains to novel alprenolol derivatives, which are represented by a specific chemical formula. These derivatives, including their hydrochlorides, showcase Kawaguchi's expertise in creating innovative pharmaceutical solutions.

Career Highlights

Kawaguchi is currently associated with Snow Brand Milk Products Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in enhancing cognitive functions and improving overall brain health.

Collaborations

Kawaguchi has collaborated with notable colleagues, including Shinichi Shimada and Masamichi Nakakoshi. Their combined expertise has contributed to the successful development of innovative pharmaceutical compounds.

Conclusion

Noboru Kawaguchi's contributions to pharmaceutical chemistry highlight his commitment to improving cognitive health through innovative inventions. His patents reflect a deep understanding of the complexities of brain function and the potential for new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…